In the life sciences industry, data is no longer just an operational asset—it is the foundation for innovation, regulatory compliance, and commercial success. From drug discovery and clinical trials to regulatory submissions and commercial operations, organizations are generating and managing unprecedented volumes of complex data.

However, many pharmaceutical, biotech, and medical device organizations still struggle with fragmented data ecosystems, inconsistent data standards, and governance frameworks that cannot keep pace with digital transformation and AI adoption. These challenges often result in poor data quality, inefficient processes, compliance risks, and limited ability to leverage advanced analytics and artificial intelligence.

The 12th Master Data and Data Governance Conference brings together senior data leaders, governance experts, and industry practitioners from across the life sciences sector to address these critical challenges and explore the strategies, technologies, and governance models shaping the future of enterprise data management.

Organized by TBM Group, the conference provides a platform for sharing real-world experiences, practical case studies, and innovative approaches to building strong Master Data Management (MDM) and Data Governance frameworks that enable trusted, high-quality, and AI-ready data across the organization.